Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.

[1]  B. Maron.  Sudden death in young athletes. , 2003, New England Journal of Medicine.

[2]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[3]  R. Virmani,et al.  Traditional Risk Factors and the Incidence of Sudden Coronary Death With and Without Coronary Thrombosis in Blacks , 2002, Circulation.

[4]  Anne L. Taylor,et al.  Race and the decision to refer for coronary revascularization: the effect of physician awareness of patient ethnicity. , 2001, Journal of the American College of Cardiology.

[5]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[6]  D. Corrado,et al.  Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. , 2000, Journal of the American College of Cardiology.

[7]  B. Maron,et al.  Preparticipation cardiovascular screening for US collegiate student-athletes. , 2000, JAMA.

[8]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[9]  H. Watkins.  Sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[10]  K A Schulman,et al.  The effect of race and sex on physicians' recommendations for cardiac catheterization. , 1999, The New England journal of medicine.

[11]  B. McCrindle,et al.  Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death. , 1998, The New England journal of medicine.

[12]  A. Moss,et al.  Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular dis , 1998, Circulation.

[13]  Barry I. Maron.  Cardiovascular Risks to Young Persons on the Athletic Field , 1998, Annals of Internal Medicine.

[14]  Asso,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[15]  B. Maron,et al.  Profile of preparticipation cardiovascular screening for high school athletes. , 1998, JAMA.

[16]  D. Atkins,et al.  Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. , 1996, Circulation.

[17]  F O Mueller,et al.  Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.

[18]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[19]  F O Mueller,et al.  Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. , 1995, The New England journal of medicine.

[20]  R. Cantu,et al.  Nontraumatic sports death in high school and college athletes. , 1995, Medicine and science in sports and exercise.

[21]  B. Maron,et al.  Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. , 1995, The American journal of cardiology.

[22]  M. Komajda,et al.  Molecular basis of familial cardiomyopathies. , 1995, Circulation.

[23]  P. Raven.  26th Bethesda Conference , 1994 .

[24]  B. Maron,et al.  Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse , 1994 .

[25]  B. Maron,et al.  26th Bethesda Conferance: Recommendations for determining eligibility for competetion in athletes with cardiovascular abnormalities , 1994 .

[26]  E. Peterson,et al.  Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. , 1994, JAMA.

[27]  B. Maron,et al.  Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. , 1993, The American journal of cardiology.

[28]  David W. Smith,et al.  Racial differences in the incidence of cardiac arrest and subsequent survival. The CPR Chicago Project. , 1993, The New England journal of medicine.

[29]  J. Whittle,et al.  Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. , 1993, The New England journal of medicine.

[30]  C. Fahrenbruch,et al.  Out-of-hospital cardiac arrest: racial differences in outcome in Seattle. , 1993, American journal of public health.

[31]  B. Maron.  Sudden death in young athletes. Lessons from the Hank Gathers affair. , 1993, The New England journal of medicine.

[32]  M. Leppert,et al.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. , 1992, The New England journal of medicine.

[33]  W. Roberts,et al.  Congenital hypoplasia of both right and left circumflex coronary arteries. , 1992, The American journal of cardiology.

[34]  A. Rimm,et al.  Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. , 1992, JAMA.

[35]  J E Smialek,et al.  Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.

[36]  D. Corrado,et al.  Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.

[37]  B. Maron,et al.  Diversity of patterns of hypertrophy in patients with systemic hypertension and marked left ventricular wall thickening. , 1990, The American journal of cardiology.

[38]  B. Lytle,et al.  Marfan's syndrome: natural history and long-term follow-up of cardiovascular involvement. , 1989, Journal of the American College of Cardiology.

[39]  A. Epstein,et al.  Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. , 1989, JAMA.

[40]  D. Corrado,et al.  Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.

[41]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[42]  C Kawai,et al.  Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. , 1986, British heart journal.

[43]  P. Yu,et al.  Progress in Cardiology , 1985 .

[44]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[45]  B. Lewis,et al.  Hypertrophic cardiomyopathy in South African Blacks. , 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[46]  J. Ruskin,et al.  Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. , 1980, The New England journal of medicine.

[47]  W. Roberts,et al.  Quantitative Analysis of Cardiac Muscle Cell Disorganization in the Ventricular Septum of Patients with Hypertrophic Cardiomyopathy , 1979, Circulation.

[48]  M. Cheitlin,et al.  Sudden Death as a Complication of Anomalous Left Coronary Origin From the Anterior Sinus of Valsalva: A Not‐So‐Minor Congenital Anomaly , 1974, Circulation.